Huntington National Bank continued to hold its position in CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 1,434 shares of the company’s stock at the end of the second quarter. Huntington National Bank’s holdings in CME Group were worth $135,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Parametrica Management Ltd bought a new position in CME Group during the second quarter valued at about $212,000. Franklin Resources Inc. acquired a new position in shares of CME Group during the first quarter valued at about $222,000. Financial Architects Inc acquired a new position in shares of CME Group during the second quarter valued at about $234,000. EFG Asset Management Americas Corp. acquired a new position in shares of CME Group during the first quarter valued at about $244,000. Finally, Windward Capital Management Co. CA raised its position in shares of CME Group by 1.0% in the second quarter. Windward Capital Management Co. CA now owns 2,626 shares of the company’s stock valued at $256,000 after buying an additional 25 shares in the last quarter. Institutional investors own 80.29% of the company’s stock.
Shares of CME Group Inc. (NASDAQ:CME) traded down 0.36% on Friday, reaching $103.82. The company’s stock had a trading volume of 844,120 shares. CME Group Inc. has a 52-week low of $81.87 and a 52-week high of $110.35. The stock has a market cap of $35.18 billion, a P/E ratio of 26.22 and a beta of 0.83. The firm’s 50 day moving average is $106.70 and its 200-day moving average is $99.42.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, July 28th. The company reported $1.14 EPS for the quarter, beating the Zacks’ consensus estimate of $1.11 by $0.03. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The firm earned $906 million during the quarter, compared to analysts’ expectations of $897.84 million. During the same quarter last year, the firm posted $0.95 earnings per share. The company’s revenue for the quarter was up 10.5% compared to the same quarter last year. On average, equities research analysts forecast that CME Group Inc. will post $4.43 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were paid a $0.60 dividend. The ex-dividend date of this dividend was Wednesday, September 7th. This represents a $2.40 dividend on an annualized basis and a yield of 2.31%. CME Group’s dividend payout ratio (DPR) is presently 60.61%.
Several brokerages recently issued reports on CME. Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $116.00 price objective for the company in a research report on Thursday, August 4th. Jefferies Group boosted their price objective on CME Group from $112.00 to $118.00 and gave the company a “buy” rating in a research report on Wednesday, August 31st. Barclays PLC decreased their price objective on CME Group from $100.00 to $99.00 and set an “equal weight” rating for the company in a research report on Friday, July 29th. JPMorgan Chase & Co. set a $116.00 price objective on CME Group and gave the company a “buy” rating in a research report on Monday, September 12th. Finally, Keefe, Bruyette & Woods boosted their target price on CME Group from $99.00 to $103.00 and gave the company a “market perform” rating in a research note on Friday, July 29th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and five have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $103.27.
In other CME Group news, insider Hilda Harris Piell sold 893 shares of the firm’s stock in a transaction that occurred on Monday, September 19th. The stock was sold at an average price of $110.00, for a total value of $98,230.00. Following the completion of the sale, the insider now owns 29,125 shares of the company’s stock, valued at $3,203,750. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction that occurred on Friday, September 2nd. The shares were sold at an average price of $109.00, for a total value of $32,700.00. Following the transaction, the director now directly owns 42,802 shares in the company, valued at approximately $4,665,418. The disclosure for this sale can be found here. 0.61% of the stock is owned by company insiders.
CME Group Company Profile
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.